• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AOMORI OLYMPUS CO., LTD. SINGLE USE ASPIRATION NEEDLE NA-U200H

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AOMORI OLYMPUS CO., LTD. SINGLE USE ASPIRATION NEEDLE NA-U200H Back to Search Results
Model Number NA-U200H-8019
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Hematoma (1884)
Date of Event 07/12/2023
Type of Reportable Event Serious Injury
Event or Problem Description
Olympus medical systems corp.(omsc) received a literature titled "guidewire malposition outside the bile duct during endoscopic ultrasound-guided hepaticogastrostomy".Endoscopic ultrasound-guided hepaticogastrostomy (eus-hgs) is widely used in clinical practice for patients with a malignant biliary obstruction after failed endoscopic retrograde cholangiopancreatography (ercp) however, the rate of procedure-related adverse events associated with eus-hgs is relatively high.Herein, we report a case of guidewire malposition during eus-hgs.An 80-year-old man with biliary obstruction due to pancreatic cancer was referred to our hospital for eus-hgs because of prior ercp failure.During the procedure, the bile duct of segment 3 was punctured using a 19-g needle (ez shot 3 plus; olympus medical, tokyo, japan), and contrast medium was injected into the bile duct.A guidewire (visi- glide 2 guidewires; olympus medical) was advanced toward the biliary tract without resistance.After dilation of the fistula, contrast was noted outside the bile duct, suggesting guidewire malposition.Eus-hgs on the bile duct of segment 2 was performed for salvage drainage.After the guidewire was inserted into the biliary tract and fistula dilation was performed, a fully covered selfexpandable metal stent (x-suit nir biliary metallic stents; olympus medical) was inserted.Although the post-eus-hgs computed tomography showed hematomas around the liver and spleen, the patient was discharged from our hospital after conservative treatment.The probable cause of incorrect advancement of the guidewire was incomplete placement of the needle tip within the bile duct.As a result, although the contrast medium was injected into the bile duct, the guidewire migrated outside the bile duct.Fluoroscopy showed that the two guidewires had a similar shape; however, their loop widths were different.Recent advances have enabled eus-hgs to be performed without fistula dilation, using a self-expandable metal stent with a small-diameter delivery system.It is necessary to evaluate the shape of the guidewire before stent placement during eus-hgs without fistula dilation.Type of adverse events/number of patients hematomas around the liver and spleen - (1).Although the post-eus-hgs computed tomography showed hematomas around the liver and spleen, the patient was discharged after conservative treatment.
 
Additional Manufacturer Narrative
Since the literature described "ez shot 3 plus", olympus selected "na-u200h-8019" as a representative product.The suspect device has not been returned to olympus for evaluation.The literature article is attached for additional information.The investigation is ongoing.A supplemental report will be submitted upon completion of the investigation or when additional information becomes available.
 
Additional Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.In addition, the malfunction of the device has not been reported, and from clinical/medical evaluation and risk assessment, it is possible that the reported event is an accident, or a complication associated with a procedure using the subject device.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SINGLE USE ASPIRATION NEEDLE NA-U200H
Common Device Name
SINGLE USE ASPIRATION NEEDLE
Manufacturer (Section D)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori 036-0 357
JA  036-0357
Manufacturer (Section G)
AOMORI OLYMPUS CO., LTD.
2-248-1 okkonoki
kuroishi-shi, aomori
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key17465696
Report Number9614641-2023-01092
Device Sequence Number11409152
Product Code FCG
UDI-Device Identifier04953170380402
UDI-Public04953170380402
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K180449
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Study,Literature,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberNA-U200H-8019
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/20/2023
Supplement Date Received by Manufacturer08/18/2023
Initial Report FDA Received Date08/04/2023
Supplement Report FDA Received Date08/25/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age80 YR
Patient SexMale
-
-